Biochips Market
Biochips Market By Product Type (DNA Chip, Protein Chip, Lab-on-a-chip), By Fabrication Technology (Microarrays, Microfluidics), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics), And By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes) - Forecast Year 2024 – 2031
Healthcare // Biotechnology
The global biochips
market is foreseen to grow at 13.5%, from USD 17.5 Billion in 2021 to USD 48.2
Billion in 2029. Growing R&D in proteomics and genomics, the presence of an
extensive drug-development pipeline, and increasing adoption of personalized
medicine is seen to propel the market growth over the forecast period. However,
unclear regulatory guidelines yet remain one of the factors restraining market
growth.
Market Definition
What is Biochip?
Biochip is a
small-scale device, analogous to an integrated circuit, constructed of or used
to analyze organic molecules associated with living organisms.
Research Scope
The report
provides market value for base year 2021 and a yearly forecast from 2022 to
2029 in terms of revenue (USD Million). Market for each segment is present on
North America, Europe, Asia Pacific, Latin America and Middle East & Africa
as well as regional basis for the above-mentioned forecast period.
Key industry
dynamics, regulatory scenario, major material dynamics and Hip replacement
devices future markets are analyzed to understand their impact on demand for
the forecast period. Growth rates have been estimated using correlation,
regression and time-series analysis.
Market Overview
Biochips market
report also provide a thorough understanding of the cutting-edge competitive
analysis of the emerging market trends along with the drivers, restraints,
challenges, and opportunities in the Biochips market to offer worthwhile
insights and current scenario for making right decision. The report covers the
prominent players in the market with detailed SWOT analysis, financial
overview, and key developments of the products/services from the past three
years. Moreover, the report also offers a 360º outlook of the market through
the competitive landscape of the global industry player and helps the companies
to garner Biochips market revenue by understanding the strategic growth
approaches.
Biochips Market
study by “Zettabyte Analytics” provides details about the market dynamics
affecting the market, Market scope, Market segmentation and overlays shadow
upon the leading market players highlighting the favorable competitive
landscape and trends prevailing over the years.
Market Segmentation
For the purpose
of this report, the global Biochips market is segmented on the basis of product
type, fabrication technology, application, end user and region:
|
By Product Type |
|
|
DNA Chip |
|
|
Protein Chip |
|
|
Lab-on-a-chip |
|
|
Other Product Types |
|
|
By Fabrication Technology |
|
|
Microarrays |
|
|
Microfluidics |
|
|
By Application |
|
|
Drug Discovery &
Development |
|
|
Disease Diagnostics |
|
|
Genomics |
|
|
Proteomics |
|
|
Agriculture |
|
|
Other Applications |
|
|
By End User |
|
|
Biotechnology &
Pharmaceutical Companies |
|
|
Hospitals &
Diagnostics Centers |
|
|
Academic & Research
Institutes |
|
|
Other End Users |
|
Product Type Outlook:
On the basis of
Product Type, the market is segmented into DNA Chip, Protein Chip,
Lab-on-a-chip, Others.
Figure 1 - Biochips Market, By Product Type (Market
Size And Forecast By Value - USD Million, 2021 & 2029)
Fabrication Technology Outlook:
On the basis of
fabrication technology, the market is segmented into microarrays, and microfluidics.
Application Outlook:
On the basis of
application, the market is segmented into drug discovery & development, disease
diagnostics, genomics, proteomics, agriculture, other applications.
Figure 2 - Application Outlook (Revenue, USD
Million, 2021)
End User Outlook:
On the basis of
end user, the market is segmented into biotechnology & pharmaceutical companies,
hospitals & diagnostics centers, academic & research institutes, other
end users.
Figure 3 - Biochips Market, By End User
(Market Size and Forecast by Value - USD Million, 2021 & 2029)
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 4 - Biochips Market: Regional dynamics
An exclusive Biochips market research report provides depth analysis of
the market dynamics across five regions such as North America, Europe, South
America, Asia-Pacific, Middle East and Africa. Further, the market has been
estimated by utilizing various research methodologies and internal statistical
model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. Some of the prominent players in the Biochips
market include:
· Abbott Laboratories
· Agendia
· Agilent
Technologies Inc.
· AMS Alliance
· ANALIS SA/NV
· Arbor Biosciences
· bioMérieux SA
· Bio-Rad
Laboratories Inc.
· Cepheid
· Dynamic Biosensors
GmbH
· Elim Biopharm Inc.
· Fluidigm
· GE Healthcare
· Genalyte Inc.
· GENERAL ELECTRIC
· Hologic Inc.
· HORIBA Ltd.
· Illumina Inc.
· Micronit
Microfluidics BV
· OriGene
Technologies Inc.
Global Biochips Market Report Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Million |
|
Revenue
forecast in 2029 |
USD 48.2 Billion |
|
Growth
Rate |
CAGR of 13.5%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product Type, Fabrication Technology,
Application, End User, Region |
|
Key
companies profiled |
Abbott
Laboratories, Agilent Technologies, Inc., PerkinElmer Inc. |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· DNA Chip
· Protein Chip
· Lab-on-a-chip
· Other Product Types
Fabrication Technology Outlook (Revenue, USD Million/Billion;
2018-2029)
· Microarrays
· Microfluidics
Application Outlook (Revenue, USD Million/Billion;
2018-2029)
· Drug Discovery
& Development
· Disease Diagnostics
· Genomics
· Proteomics
· Agriculture
·
Other Applications
End User Outlook (Revenue, USD Million/Billion;
2018-2029)
· Biotechnology &
Pharmaceutical Companies
· Hospitals &
Diagnostics Centers
· Academic &
Research Institutes
·
Other End Users
Regional Outlook (Revenue, USD Million/Billion;
2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Key Benefits of the Report:
· Global, regional,
country, product type, fabrication technology, application, end user, and
market size and their forecast from 2018-2029.
· Identification and
detailed analysis on key market dynamics, such as, drivers, restraints,
opportunities, and challenges influencing growth of the market
· Detailed analysis
on industry outlook with market specific PESTLE, and supply chain to better
understand the market and build expansion strategies
· Identification of
key market players and comprehensively analyze their market share and core
competencies, detailed financial positions, key products, and unique selling
points
· Analysis on key
players’ strategic initiatives and competitive developments, such as Collaborations,
mergers, and new product launches in the market
· Expert interviews
and their insights on market shift, current and future outlook, and factors
impacting vendors’ short term and long-term strategies
· Detailed insights
on emerging regions, product type, fabrication technology, application, end
user, and options with qualitative and quantitative information and fact
|
Chapter 1. Introduction |
|
1.1. Market Definition |
|
1.2. Research Scope |
|
1.2.1. Markets Covered |
|
1.2.2. Years Considered for Study |
|
Chapter 2. Research Methodology |
|
2.1.
Research Sources |
|
2.1.1. Primary |
|
2.1.2. Secondary |
|
2.2. Market Size Estimation |
|
Chapter 3. Executive Summary |
|
3.1. Summary Snapshot Market Size and Forecast, 2018-2029 |
|
3.2. Biochips Market Share by Product Type, 2021 vs 2029 (USD Million)
|
|
3.3. Biochips Market Share by Fabrication Technology, 2021 vs 2029
(USD Million) |
|
3.4. Biochips Market Share by Application, 2021 vs 2029 (USD Million) |
|
3.5. Biochips Market Share by End User, 2021 vs 2029 (USD Million) |
|
3.5. Biochips Market Share by Region, 2021 vs 2029 (USD Million) |
|
Chapter 4. Key Insights |
|
Chapter 5. Biochips Market Segmentation &
Impact Analysis |
|
5.1. Biochips Market Indicators Analysis |
|
5.1.1. Market Drivers Analysis |
|
5.1.1.1. Increase in
adoption of next-generation sequencing |
|
5.1.1.2. Growing
R&D in proteomics and genomics |
|
5.1.1.3. Presence of
an extensive drug-development pipeline |
|
5.1.2. Market Restraint Analysis |
|
5.1.2.1. High cost
of manufacturing |
|
5.1.3. Market Opportunity Analysis |
|
5.2. Regulatory Analysis |
|
5.2.1. North America |
|
5.2.1.1. U.S. |
|
5.2.1.2. Canada |
|
5.2.2. Europe |
|
5.2.2. Asia Pacific |
|
5.2.2.1. India |
|
5.2.2.2. Japan |
|
5.2.2.3. China |
|
5.3. Technological Insights |
|
5.4. COVID-19 Impact analysis on Biochips Market |
|
5.5. Porter’s Five Forces Analysis |
|
5.5.1. Bargaining Power of Buyers/Consumers |
|
5.5.2. Bargaining Power of Suppliers |
|
5.5.3. Threat of New Entrants |
|
5.5.4. Threat of Substitute Products |
|
5.5.5. Intensity of Competitive Rivalry |
|
5.6.
Competitive Metric Space Analysis |
|
Chapter 6. Biochips Market, By Product
Type (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
6.1. Biochips Market, By Product Type (Market Size and Forecast by
Value - USD Million, 2021 & 2029) |
|
6.1.1. DNA Chip |
|
6.1.1.1. DNA Chip Market Estimates and Forecast,
2019-2029 (USD Million) |
|
6.1.1.2.
DNA Chip Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
6.1.2. Protein Chip |
|
6.1.2.1. Protein
Chip Market Estimates and Forecast, 2019-2029 (USD Million) |
|
6.1.2.2. Protein
Chip Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
6.1.3. Lab-on-a-chip |
|
6.1.3.1.
Lab-on-a-chip Market Estimates and Forecast, 2019-2029 (USD Million) |
|
6.1.3.2.
Lab-on-a-chip Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
6.1.4. Others |
|
6.1.4.1. Others Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
6.1.4.2. Others
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Chapter 7. Biochips Market, By
Fabrication Technology (Market Size and Forecast by Value - USD Million, 2018
- 2029) |
|
7.1. Biochips Market, By Fabrication Technology (Market Size and
Forecast by Value - USD Million, 2021 & 2029) |
|
7.1.1. Microarrays |
|
7.1.1.1. Microarrays Market Estimates and Forecast,
2019-2029 (USD Million) |
|
7.1.1.2. Microarrays Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
7.1.2. Microfluidics |
|
7.1.2.1. Microfluidics Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
7.1.2.2. Microfluidics Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
Chapter 8. Biochips Market, By
Application (Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
8.1. Biochips Market, By Application
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
8.1.1. Drug Discovery &
Development |
|
8.1.1.1. Drug Discovery & Development Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
8.1.1.2. Drug Discovery & Development Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
8.1.2. Disease Diagnostics |
|
8.1.2.1. Disease Diagnostics Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
8.1.2.2. Disease Diagnostics Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
8.1.3. Genomics |
|
8.1.3.1. Genomics
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
8.1.3.2. Genomics
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
8.1.4. Proteomics |
|
8.1.4.1. Proteomics
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
8.1.4.2. Proteomics
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
8.1.5. Agriculture |
|
8.1.5.1. Agriculture
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
8.1.5.2. Agriculture
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
8.1.6. Other Applications |
|
8.1.6.1. Other
Applications Market Estimates and Forecast, 2019-2029 (USD Million) |
|
8.1.6.2. Other
Applications Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
Chapter 9. Biochips Market, By End User
(Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
9.1. , By End User (Market Size and Forecast by Value - USD Million,
2021 & 2029) |
|
9.1.1. Biotechnology &
Pharmaceutical Companies |
|
9.1.1.1. Biotechnology
& Pharmaceutical Companies Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
9.1.1.2.
Biotechnology & Pharmaceutical Companies Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
9.1.2. Hospitals &
Diagnostics Centers |
|
9.1.2.1. Hospitals
& Diagnostics Centers Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
9.1.2.2. Hospitals
& Diagnostics Centers Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
9.1.3. Academic & Research
Institutes |
|
9.1.3.1. Academic
& Research Institutes Market Estimates and Forecast, 2019-2029 (USD Million) |
|
9.1.3.2. Academic
& Research Institutes Market Estimates and Forecast, By Region, 2019-2029
(USD Million) |
|
9.1.4. Other End Users |
|
9.1.4.1. 10A Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
9.1.4.2. 10A Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Chapter 10. Biochips Market, By Region
(Market Size and Forecast by Value - USD Million, 2018 - 2029) |
|
10.1. Biochips Market, By Region (Market Size and Forecast by Value -
USD Million, 2021 & 2029) |
|
10.2. North America |
|
10.2.1. North America Biochips
Market, By Product Type, 2018-2029 (USD Million) |
|
10.2.2. North America Biochips
Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.2.3. North America Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.2.4. North America Biochips
Market, By End User, 2018-2029 (USD Million) |
|
10.2.5. North America Biochips
Market, By Country, 2018-2029 (USD Million) |
|
10.2.6. U.S. |
|
10.2.6.1. U.S.
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.2.6.2. U.S. Biochips Market,
By Fabrication Technology, 2018-2029 (USD Million) |
|
10.2.6.3. U.S.
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.2.6.3. U.S.
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.2.7. Canada |
|
10.2.7.1. Canada
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.2.7.2. Canada
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.2.7.3. Canada
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.2.7.3. Canada Biochips
Market, By End User, 2018-2029 (USD Million) |
|
10.3. Europe |
|
10.3.1. Europe Biochips Market,
By Product Type, 2018-2029 (USD Million) |
|
10.3.2. Europe Biochips Market,
By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.3. Europe Biochips Market,
By Application, 2018-2029 (USD Million) |
|
10.3.4. EuropeBiochips Market,
By End User, 2018-2029 (USD Million) |
|
10.3.5. Europe Biochips Market,
By Country, 2018-2029 (USD Million) |
|
10.3.6. Germany |
|
10.3.6.1. Germany
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.3.6.2. Germany
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.6.3. Germany
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.3.6.3. Germany
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.3.7. U.K. |
|
10.3.7.1. U.K. Biochips Market, By
Product Type, 2018-2029 (USD Million) |
|
10.3.7.2. U.K.
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.7.3. U.K. Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.3.7.3. U.K.
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.3.8. France |
|
10.3.8.1. France
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.3.8.2. France
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.8.3. France
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.3.8.3. France
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.3.9. Spain |
|
10.3.9.1. Spain
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.3.9.2. Spain
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.9.3. Spain
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.3.9.3. Spain Biochips
Market, By End User, 2018-2029 (USD Million) |
|
10.3.10. Italy |
|
10.3.10.1. Italy
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.3.10.2. Italy
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.10.3. Italy
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.3.10.3. Italy
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.3.11. Rest of Europe |
|
10.3.11.1. Rest
of Europe Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.3.11.2. Rest
of Europe Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.3.11.3. Rest
of Europe Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.3.11.3. Rest
of Europe Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4. Asia Pacific |
|
10.4.1. Asia Pacific Biochips
Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.2. Asia Pacific Biochips
Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.3. Asia Pacific Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.4.4. Asia Pacific Biochips
Market, By End User, 2018-2029 (USD Million) |
|
10.4.5. Asia Pacific Biochips
Market, By Country, 2018-2029 (USD Million) |
|
10.4.6. India |
|
10.4.6.1. India
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.6.2. India
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.6.3. India
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.4.6.3. India
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4.7. Japan |
|
10.4.7.1. Japan
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.7.2. Japan
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.7.3. Japan Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.4.7.3. Japan
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4.8. China |
|
10.4.8.1. China
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.8.2. China
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.8.3. China
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.4.8.3.
China Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4.9. South Korea |
|
10.4.9.1. South
Korea Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.9.2. South Korea Biochips Market,
By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.9.3. South
Korea Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.4.9.3. South
Korea Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4.10. Australia |
|
10.4.10.1. Australia
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.10.2.
Australia Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.4.10.3.
Australia Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.4.10.3.
Australia Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.4.11. Rest of Asia Pacific |
|
10.4.11.1. Rest
of Asia Pacific Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.4.11.2. Rest
of Asia Pacific Biochips Market, By Fabrication Technology, 2018-2029 (USD
Million) |
|
10.4.11.3. Rest
of Asia Pacific Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.4.11.3. Rest
of Asia Pacific Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.5. Middle East & Africa |
|
10.5.1. Middle East &
Africa Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.5.2. Middle East &
AfricaBiochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.5.3. Middle East & Africa
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.5.4. Middle East &
Africa Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.5.5. Middle East &
Africa Biochips Market, By Country, 2018-2029 (USD Million) |
|
10.5.6. UAE |
|
10.5.6.1. UAE
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.5.6.2. UAE
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.5.6.3. UAE
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.5.6.3. UAE
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.5.7. Saudi Arabia |
|
10.5.7.1. Saudi
Arabia Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.5.7.2. Saudi
Arabia Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.5.7.3. Saudi
Arabia Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.5.7.3. Saudi
Arabia Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.5.8. South Africa |
|
10.5.8.1. South Africa
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.5.8.2. South
Africa Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.5.8.3. South
Africa Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.5.8.3. South
Africa Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.5.9. Rest of Middle East
& Africa |
|
10.5.9.1. Rest of
Middle East & Africa Biochips Market, By Product Type, 2018-2029 (USD
Million) |
|
10.5.9.2. Rest of
Middle East & Africa Biochips Market, By Fabrication Technology,
2018-2029 (USD Million) |
|
10.5.9.3. Rest of
Middle East & Africa Biochips Market, By Application, 2018-2029 (USD
Million) |
|
10.5.9.3. Rest of
Middle East & Africa Biochips Market, By End User, 2018-2029 (USD
Million) |
|
10.6. Latin America |
|
10.6.1. Latin America Biochips
Market, By Product Type, 2018-2029 (USD Million) |
|
10.6.2. Latin America Biochips
Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.6.3. Latin America Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.6.4. Latin America Biochips
Market, By End User, 2018-2029 (USD Million) |
|
10.6.5. Latin America Biochips
Market, By Country, 2018-2029 (USD Million) |
|
10.6.6. Brazil |
|
10.6.6.1. Brazil Biochips Market, By
Product Type, 2018-2029 (USD Million) |
|
10.6.6.2. Brazil
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.6.6.3. Brazil
Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.6.6.3. Brazil
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.6.7. Mexico |
|
10.6.7.1. Mexico
Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.6.7.2. Mexico
Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.6.7.3. Mexico Biochips
Market, By Application, 2018-2029 (USD Million) |
|
10.6.7.3. Mexico
Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.6.8. Argentina |
|
10.6.8.1.
Argentina Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.6.8.2.
Argentina Biochips Market, By Fabrication Technology, 2018-2029 (USD Million) |
|
10.6.8.3.
Argentina Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.6.8.3.
Argentina Biochips Market, By End User, 2018-2029 (USD Million) |
|
10.6.9. Rest of Latin America |
|
10.6.9.1. Rest of
Latin America Biochips Market, By Product Type, 2018-2029 (USD Million) |
|
10.6.9.2. Rest of
Latin America Biochips Market, By Fabrication Technology, 2018-2029 (USD
Million) |
|
10.6.9.3. Rest of
Latin America Biochips Market, By Application, 2018-2029 (USD Million) |
|
10.6.9.3. Rest of
Latin America Biochips Market, By End User, 2018-2029 (USD Million) |
|
Chapter 11. Competitive Landscape |
|
11.1. Market Revenue Share by Manufacturers |
|
11.2.
Competitor’s Positioning |
|
11.3. Strategy Benchmarking |
|
11.3.1. Company Overview |
|
11.3.2. Products Offered |
|
11.3.3. Financials |
|
11.3.4. Recent
Development |
|
11.4. Vendor Landscape |
|
11.4.1. Distributors |
|
11.4.2. North America |
|
11.4.3. Europe |
|
11.4.4. Asia Pacific |
|
11.4.5. Middle East &
Africa |
|
11.4.6. Latin America |
|
11.5.
Zettabyte Analytics Insights for Competitive Landscape |
|
Chapter 12. Company Profiles |
|
12.1. Abbott Laboratories |
|
12.1.1. Company Overview |
|
12.1.2. Products Offered |
|
12.1.3. Financials |
|
12.1.4. Recent
Development |
|
12.2. Agendia |
|
12.2.1. Company Overview |
|
12.2.2. Products Offered |
|
12.2.3. Financials |
|
12.2.4. Recent
Development |
|
12.3.
Agilent Technologies Inc. |
|
12.3.1. Company Overview |
|
12.3.2. Products Offered |
|
12.3.3. Financials |
|
12.3.4. Recent
Development |
|
12.4. AMS Alliance |
|
12.4.1. Company Overview |
|
12.4.2. Products Offered |
|
12.4.3. Financials |
|
12.4.4. Recent
Development |
|
12.5. ANALIS SA/NV |
|
12.5.1. Company Overview |
|
12.5.2. Products Offered |
|
12.5.3. Financials |
|
12.5.4. Recent
Development |
|
12.6. Arbor Biosciences |
|
12.6.1. Company Overview |
|
12.6.2. Products Offered |
|
12.6.3. Financials |
|
12.6.4. Recent Development |
|
12.7. bioMérieux SA |
|
12.7.1. Company Overview |
|
12.7.2. Products Offered |
|
12.7.3. Financials |
|
12.7.4. Recent
Development |
|
12.8.
Bio-Rad Laboratories Inc. |
|
12.8.1. Company Overview |
|
12.8.2. Products Offered |
|
12.8.3. Financials |
|
12.8.4. Recent
Development |
|
12.9. Cepheid |
|
12.9.1. Company Overview |
|
12.9.2. Products Offered |
|
12.9.3. Financials |
|
12.9.4. Recent
Development |
|
12.10. Dynamic Biosensors GmbH |
|
12.10.1. Company Overview |
|
12.10.2. Products Offered |
|
12.10.3. Financials |
|
12.10.4. Recent
Development |
|
12.11. Elim Biopharm Inc. |
|
12.11.1. Company Overview |
|
12.11.2. Products Offered |
|
12.11.3. Financials |
|
12.11.4. Recent
Development |
|
12.12. Fluidigm |
|
12.12.1. Company Overview |
|
12.12.2. Products Offered |
|
12.12.3. Financials |
|
12.12.4. Recent
Development |
|
12.13.
GE Healthcare |
|
12.13.1. Company Overview |
|
12.13.2. Products Offered |
|
12.13.3. Financials |
|
12.13.4. Recent
Development |
|
12.14. Genalyte Inc. |
|
12.14.1. Company Overview |
|
12.14.2. Products Offered |
|
12.14.3. Financials |
|
12.14.4. Recent
Development |
|
12.15. GENERAL ELECTRIC |
|
12.15.1. Company Overview |
|
12.15.2. Products Offered |
|
12.15.3. Financials |
|
12.15.4. Recent
Development |
|
12.16. Hologic Inc. |
|
12.16.1. Company Overview |
|
12.16.2. Products Offered |
|
12.16.3. Financials |
|
12.16.4. Recent
Development |
|
12.17. HORIBA Ltd. |
|
12.17.1. Company Overview |
|
12.17.2. Products Offered |
|
12.17.3. Financials |
|
12.17.4. Recent
Development |
|
12.18. Illumina Inc. |
|
12.18.1. Company Overview |
|
12.18.2. Products Offered |
|
12.18.3. Financials |
|
12.18.4. Recent
Development |
|
12.19. Micronit Microfluidics BV |
|
12.19.1. Company Overview |
|
12.19.2. Products Offered |
|
12.19.3. Financials |
|
12.19.4. Recent
Development |
|
12.20. OriGene Technologies Inc. |
|
12.20.1. Company Overview |
|
12.20.2. Products Offered |
|
12.20.3. Financials |
|
12.20.4. Recent
Development |
|
12.21. PerkinElmer Inc. |
|
12.21.1. Company Overview |
|
12.21.2. Products Offered |
|
12.21.3. Financials |
|
12.21.4. Recent
Development |
|
12.22. QIAGEN N.V. |
|
12.22.1. Company Overview |
|
12.22.2. Products Offered |
|
12.22.3. Financials |
|
12.22.4. Recent
Development |
|
12.23. Randox Laboratories Ltd. |
|
12.23.1. Company Overview |
|
12.23.2. Products Offered |
|
12.23.3. Financials |
|
12.23.4. Recent
Development |
|
12.24. Roche Diagnostics |
|
12.24.1. Company Overview |
|
12.24.2. Products Offered |
|
12.24.3. Financials |
|
12.24.4. Recent
Development |
|
12.25. Thermo Fisher Scientific, Inc. |
|
12.25.1. Company Overview |
|
12.25.2. Products Offered |
|
12.25.3. Financials |
|
12.25.4. Recent
Development |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States